Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04772235 |
Title | Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (TOTEM) |
Acronym | TOTEM |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Instituto Oncologico Dr Rosell |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Hospital Regional Universitario de Málaga | RECRUITING | Málaga | Andalucia | 29010 | Spain | Details |
Hospital Son Espases | RECRUITING | Palma | Baleares | 07120 | Spain | Details |
Quiron Dexeus | RECRUITING | Barcelona | Cataluña | 08018 | Spain | Details |
Hospital Universitario Gregorio Marañón | RECRUITING | Madrid | 28007 | Spain | Details |